Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

4.2K
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
4.2K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

405
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
405
Pyruvate Oxidation01:15

Pyruvate Oxidation

165.6K
After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
165.6K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

1.6K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.6K
Peroxisomes01:24

Peroxisomes

17.2K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
17.2K
Pleiotropy01:33

Pleiotropy

41.8K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
41.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RNA Sequencing Indicates Distinct Platelet Transcriptomic Changes in Immune Thrombocytopenia.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Value of functional iron parameters in diagnostic re-assessment of MPN: refinement of iron-deficiency markers by zinc protoporphyrin (ZPP).

Annals of hematology·2026
Same author

Guidelines for the management of acute porphyria: recommendations from the International Porphyria Network.

The Lancet. Haematology·2026
Same author

Liver graft as a 'Trojan horse': manifestation of variegate porphyria in an 11-month-old girl with biliary atresia after living-related liver transplantation.

Gastroenterology report·2026
Same author

Biallelic pathogenic hydroxymethylbilane synthase gene variants of a neurodegenerative disorder with progressive cystic leukoencephalopathy: a case report.

Journal of medical case reports·2026
Same author

Sequential or upfront triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma: the MONTBLANC trial protocol (AIO-HEP-0325/ass).

Therapeutic advances in medical oncology·2026

Related Experiment Video

Updated: Oct 31, 2025

Author Spotlight: Porphyrin-Modified Beads for Use as Compensation Controls in Flow Cytometry
10:06

Author Spotlight: Porphyrin-Modified Beads for Use as Compensation Controls in Flow Cytometry

Published on: March 24, 2023

2.7K

[Porphyria].

Ulrich Stölzel1, Thomas Stauch2, Ilja Kubisch3

  • 1Porphyrie Zentrum, Klinikum Chemnitz gGmbH, Flemmingstr. 2, 09009, Chemnitz, Deutschland. dr.stoelzel@porphyrie.de.

Der Internist
|June 29, 2021
PubMed
Summary
This summary is machine-generated.

Porphyrias are genetic disorders affecting heme production, leading to diverse symptoms like abdominal pain and skin sensitivity. Diagnosis involves biochemical tests, and various treatments are available for acute and non-acute forms.

Keywords:
Abdominal painHemeLiver damageParesisPhotosensitivity

More Related Videos

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

12.1K
One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles
09:51

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles

Published on: September 17, 2013

11.0K

Related Experiment Videos

Last Updated: Oct 31, 2025

Author Spotlight: Porphyrin-Modified Beads for Use as Compensation Controls in Flow Cytometry
10:06

Author Spotlight: Porphyrin-Modified Beads for Use as Compensation Controls in Flow Cytometry

Published on: March 24, 2023

2.7K
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

12.1K
One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles
09:51

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles

Published on: September 17, 2013

11.0K

Area of Science:

  • Biochemistry
  • Genetics
  • Internal Medicine

Background:

  • Porphyrias are a group of genetic disorders resulting from enzyme deficiencies in the heme biosynthetic pathway.
  • These deficiencies lead to the accumulation of porphyrins and/or porphyrin precursors in the body.
  • Accumulated metabolites can cause a range of clinical manifestations, including neurological, psychiatric, and dermatological symptoms.

Purpose of the Study:

  • To provide an overview of the classification and clinical presentation of porphyrias.
  • To highlight diagnostic biochemical patterns.
  • To discuss available and emerging treatment options for different porphyria types.

Main Methods:

  • Biochemical analysis of porphyrins and precursors in biological samples (urine, feces, blood).
  • Classification of porphyrias into acute and non-acute forms based on clinical and biochemical profiles.
  • Review of current and investigational therapeutic strategies.

Main Results:

  • Diagnosis relies on identifying specific biochemical signatures of elevated porphyrins and precursors.
  • Acute hepatic porphyrias involve porphyrin precursor accumulation (e.g., 5-aminolevulinic acid, porphobilinogen) causing systemic symptoms.
  • Non-acute porphyrias are characterized by porphyrin accumulation leading to photosensitivity and potential liver damage.

Conclusions:

  • Porphyrias encompass a spectrum of disorders with distinct biochemical and clinical phenotypes.
  • Accurate diagnosis through biochemical testing is crucial for appropriate management.
  • Effective treatment strategies, both established and novel, exist for most porphyria types, improving patient outcomes.